Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For XPS.L
Valuation Weak
14%
Profitability n.A.
Fin. Growth n.A.
Leverage & Liquidity Weak
33%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q4 Δ in %
Current Ratio inf 0.00 1.37
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -92.22 0.35 4.50
Naive Interpretation member
2 Per Share
Metric Q2 Q4 Δ in %
Book Value 31.49 0.90 0.68
Cash 72.70 0.05 0.03
Capex 17.42 -0.02 -0.02
Free Cash Flow 437.38 0.13 0.02
Revenue 45.37 0.66 0.46
Naive Interpretation member
3 Profitability
Metric Q2 Q4 Δ in %
Gross Margin 0.10 1.00 1.00
Operating Margin 272.20 0.42 0.11
ROA 778.54 0.17 0.02
ROE 577.89 0.26 0.04
ROIC 643.43 0.25 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of XPS.L is permitted for members.
5 Growth
The "Growth Entry" for the Focus of XPS.L is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of XPS.L is permitted for members.